Jaguar Animal Health (JAGX)

Jaguar Animal Health (JAGX) Stock Price & Analysis


JAGX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.46 - $28.82
Previous Close$0.68
Average Volume (3M)3.56M
Market Cap
Enterprise Value$23.07M
Total Cash (Recent Filing)$14.37M
Total Debt (Recent Filing)$34.30M
Price to Earnings (P/E)>-0.1
Aug 17, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-23.46
Shares Outstanding19,105,631
10 Day Avg. Volume1,816,027
30 Day Avg. Volume3,556,572
Standard Deviation0.48
Financial Highlights & Ratios
Price to Book (P/B)-0.68
Price to Sales (P/S)6.63
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.04
Enterprise Value/Gross Profit2.32
Enterprise Value/Ebitda-0.80
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Jaguar Animal Health’s price range in the past 12 months?
Jaguar Animal Health lowest stock price was $0.46 and its highest was $28.82 in the past 12 months.
    What is Jaguar Animal Health’s market cap?
    Currently, no data Available
    When is Jaguar Animal Health’s upcoming earnings report date?
    Jaguar Animal Health’s upcoming earnings report date is Aug 17, 2023 which is in 82 days.
      How were Jaguar Animal Health’s earnings last quarter?
      Jaguar Animal Health released its earnings results on May 15, 2023. The company reported -$2.39 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.39.
        Is Jaguar Animal Health overvalued?
        According to Wall Street analysts Jaguar Animal Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Jaguar Animal Health pay dividends?
          Jaguar Animal Health does not currently pay dividends.
          What is Jaguar Animal Health’s EPS estimate?
          Jaguar Animal Health’s EPS estimate is -$1.53.
            How many shares outstanding does Jaguar Animal Health have?
            Jaguar Animal Health has 2,016,335 shares outstanding.
              What happened to Jaguar Animal Health’s price movement after its last earnings report?
              Jaguar Animal Health reported an EPS of -$2.39 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -22.449%.
                Which hedge fund is a major shareholder of Jaguar Animal Health?
                Currently, no hedge funds are holding shares in JAGX


                Jaguar Animal Health Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Jaguar Animal Health

                Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.


                Top 5 ETFs holding JAGX

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold JAGX. The ETFs are listed according to market value of JAGX within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Emmaus Life Sciences
                Clever Leaves Holdings
                CB Scientific
                Acer Therapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis